It is currently Fri Dec 09, 2016 9:31 am

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

RE MS DRUG MAY ALREADY BE OUT THERE

HI Friends please read
http://www.bbc.com/news/health-32136208
regards
seeva
Read more : RE MS DRUG MAY ALREADY BE OUT THERE | Views : 1728 | Replies : 0


RE DRUG SCCESSFULLY RESTORES MYELIN IN PHASE2 TRAIL

HI Friends Anti LINGO1 was tested in the RENEW trail
please read more
http://www.hcplive.com/news/Drug-Succes ... e-2-Trial-
regards
seeva
Read more : RE DRUG SCCESSFULLY RESTORES MYELIN IN PHASE2 TRAIL | Views : 1746 | Replies : 0


Remyelination

http://www.gizmag.com/indazole-chloride ... a-90024906


This is the article I mentioned in another post - it may be here in less detail but this includes the researchers and some details on where the drug is derived from - oestrogen.

J :)
Read more : Remyelination | Views : 1554 | Replies : 2


BG 12

My ins won't cover tecfidera, I found a compounding pharm where I can get 115 mg Di methyl fumarate for 150.00 per month
Tec would cost 11,000 per month.......they are proud of it....lol
I started it 3 days ago, feeling very tired...is this common when first started? I will keep pushing forward. I was on BG 12 yrs ago before tec came out. I don't remember the tiredness. But I have been taking sleeping meds ...
Read more : BG 12 | Views : 1475 | Replies : 4










RE COLD MICROPATICLES LEAD TO SPMS THERAPY

HI Friends Newszealand and Australian based companies designed and manufactured a micropaticiles can be used fight SPMS AND CANCERS
Read more attached
http://multiplesclerosisnewstoday.com/2 ... ign=buffer
regards
seeva
Read more : RE COLD MICROPATICLES LEAD TO SPMS THERAPY | Views : 1203 | Replies : 0


MCC 950 MS Progress from Older Drug

I heard about this drug yesterday (Feb 18) which was discovered by scientists at the University of Queensland.

They worked with an international team to develop a molecule that fights one of the main causes of inflammatory diseases, a breakthrough researchers say could lead to safer and cheaper treatments.

Alzheimer's, arthritis and multiple sclerosis treatments could be improved by Queensland scientists' development of MCC950 molecule

MCC950 is a potent and specific inhibitor of the NLRP3 ...
Read more : MCC 950 MS Progress from Older Drug | Views : 2250 | Replies : 0


 

Login  •  Register


Statistics

Total posts 235160 • Total topics 25378 • Total members 16585


Contact us | Terms of Service